HomePRN • TSE
Profound Medical Corp
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 2.62M | 82.14% |
Operating expense | 13.02M | 48.91% |
Net income | -10.72M | -62.85% |
Net profit margin | -409.16 | 10.59% |
Earnings per share | -0.50 | -40.66% |
EBITDA | -11.00M | -44.26% |
Effective tax rate | -0.38% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 46.43M | 12.76% |
Total assets | 60.86M | 6.07% |
Total liabilities | 10.07M | -12.58% |
Total equity | 50.79M | — |
Shares outstanding | 30.05M | — |
Price to book | 4.32 | — |
Return on assets | -42.59% | — |
Return on capital | -46.06% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -10.72M | -62.85% |
Cash from operations | -8.28M | -82.89% |
Cash from investing | — | — |
Cash from financing | -290.00K | -101.42% |
Net change in cash | -8.48M | -156.65% |
Free cash flow | -4.69M | -53.40% |
Previous close
$7.30
Day range
$7.21 - $7.38
Year range
$5.58 - $15.75
Market cap
216.68M CAD
Avg Volume
10.22K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
About
Founded
2008
Headquarters
Website
Employees
142